Search PubMed⌕ Search

Biomedical subjects

T Arima

Publications and source records attributed to T Arima.

At least 307 records · Page 17Linked to original sources

Regular structures on the microvillar surface membrane of ileal epithelial cells in suckling rat intestine.

Freeze-fracture deep-etch studies were done to examine regular patterns of surface membrane particles in the suckling rat ileal epithelium by using quick-freezing method. In addition to the presence on the luminal surfaces of well-developed endocytic complexes, latticed particles were consistently observed on almost the entire apical membrane between microvilli and frequently on the microvilli. These particles seemed to be partly integrated in the outer half layer of membranes. After rinsing with phosphate-buffered saline, patterns on the microvilli appeared to be parallel circle lines rather than latticed particles found in fresh preparations. Filipin treatment showed the presence of filipin-sterol complexes on most of the particle-covered membrane areas except small tubules and vesicles. Possibilities were suggested that these latticed particles were transferred to the apical surface along the outer half layer of membranes, and released or secreted into the intestinal lumen.

Animals↗

Increased 125I-labelled concanavalin A binding to erythrocytes in diabetes mellitus.

Percentage binding of 125 I-labelled concanavalin A to erythrocytes in diabetic patients was significantly higher than that in normal subjects (12.2 +/- 2.8 versus 8.1 +/- 1.8%, mean +/- SD, p less than 0.001). Insulin-dependent diabetic patients showed significantly higher concanavalin A binding than non-insulin-dependent diabetic subjects (15.0 +/- 1.4 versus 11.4 +/- 2.5%, p less than 0.01). There was a highly significant correlation between percentage binding of 125I-labelled concanavalin A and glycosylated haemoglobin.

Adult↗

Insulin binding to erythrocytes in diabetes mellitus.

Insulin binding to erythrocytes was studied in diabetic patients. Insulin binding was lower in untreated diabetics and diabetic patients treated with diet or insulin than in normal subjects. Binding variation was mainly due to decreased binding site concentration in untreated and insulin-treated patients, and to lowered insulin binding site affinity in diet-treated patients. Several patients treated with hypoglycemic agents showed higher insulin binding due to increased binding site concentration. Insulin binding to erythrocytes may not always reflect the insulin binding status of insulin sensitive tissues.

Diabetes Mellitus↗

[Studies on computer processing of fetal heart beat intervals with the comparison to several analyzing methods (author's transl)].

Fetal heart beat intervals are statistically studied with the use of direct fetal ECG signal, universal counter module, HP 2100 A computer and fetal heart rate meter. In 78 cases of labor, 260 data trains which are composed of 250 beat intervals respectively are utilized for the study. Fetal heart rate curves are classified into Hammacher's 4 oscillation types. Every beat interval (BI), beat interval difference (ID) are studied with the comparison to interval index (II) and differential index (DI) of Yeh, and long term irregularity index (LTI) and short term irregularity index (STI) of de Haan. Among 4 oscillation types, ID value is the least in type 0, the next in type 1 then 2, and the largest in type 3. The differences are significant respectively. Percentages of ID below 1 ms histogram showed the largest value in type 0, the next in type 1 then 2, and the least in type 3. The differences are significant respectively. Normal type 2 and abnormal type 0 cases are compared by STI, DI and ID. Mean value of STI shows no difference between the cases, but the SD is very small in type 0. DI is small in type 0, and mean and SD of ID of the author are small in type 0. The utility of ID is suspected from the results in this study.¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿¿

Adult↗

Studies on circulating immune complexes of the liver disease. 3. Conditions for Clq binding assay and low molecular weight Clq reactants.

Assay conditions for Clq binding activity (ClqBA) of aggregated human gamma globulin and pathologic sera were studied. The Clq component of complement was isolated by precipitation method and effectively radioiodinated using lactoperoxidase without loss of binding activity. The assay method was reproducible and the binding activity of normal sera was 5.0 +/- 2.4% (mean +/- S.D.). Amount of 125I-Clq, in the range of 50--1000 ng per assay tube, did not influence the binding activity. Competitive inhibition of intrinsic Clq was very limited. Sample sera for the determination can be stored at --20 degrees C and freezing-throwing of the sera did not increase ClqBA. In normal sera, the existence of solubilizer of Clq-reactant-complex or inhibitor of Clq-reactant binding working at 37 degrees C is suggested. For the low molecular weight reactants in pathologic sera reacting with Clq at 4 degrees C, following substances are proposed: 1. abnormal IgG, 2. hapten-IgG complexes or 3. anionic substances.

Antigen-Antibody Complex↗

Studies on circulating immune complexes of the liver disease. 4. Clq binding activity.

Serum Clq binding activity (ClqBA) is increased in diabetes mellitus with liver injury, carcinoma of gastrointestinal tract with metastatic liver and chronic liver disease (CLD). Significant elevations of ClqBA level are observed in the order of liver cirrhosis, chronic aggressive hepatitis and chronic persistent hepatitis. In CLD there are significant correlations between ClqBA and gamma-globulin, rheumatoid factor, anti-DNA-antibody, CH50, C3, C4, C3-activator and HBsAg.

Antibodies, Antinuclear↗

Studies on acid protease fractions and gastric mucosal atrophy. 3. Special reference to peptic ulcers.

In combination with routine gastric secretion test and endoscopic congo red test, alkali labile pepsin (ALP) and alkali stable pepsin (ASP) were separately determined in total of 41 patients with peptic ulcer including 20 gastric (GU), 12 duodenal (DU) and 9 gastroduodenal ulcers (GDU), and in 10 normal controls. In both of basal and tetragastrin stimulated states, percent of ASP in total acid protease (%ASP) was increased in order of GU, GDU, normal control and DU with a close relation to the dimension of acid secreting area determined by endoscopic congo red test. Percent ASP was decreased after tetragastrin provocation in all disease groups. GU had high % ASP and low maximal acid output (MAO), GDU had high %ASP and high MAO, and DU showed low %ASP and high MAO.

Adult↗

Studies on secretory component in digestive disease. IV. Levels of serum secretory component in liver disease.

The levels of serum secretory component (SC), immunoglobulins, rheumatoid factor, HBs-antigen and HBs-antibody were determined in patients with liver disease, especially chronic liver disease. In chronic liver disease, decreases in serum SC were accompanied by increases in the titer of rheumatoid factor. Patients with chronic liver disease and HBs-antigen or HBs-antibody had decreased levels of serum SC compared to seronegative patients. There was no correlation between the levels of serum SC and immunoglobulin in patients with chronic liver disease.

Adult↗

Serum secretory component level in myeloma patients with disorders of the secretory surface.

Secretory component (SC) in myeloma serum was measured by a double antibody radioimmunoassay. It was elevated in patients with IgA myeloma and the highest level was observed in a patient with macroglobulinemia. The presence of disorders of secretory surface in myeloma patients slightly but not significantly elevated the serum SC concentration. A significant correlation between serum SC and IgG is demonstrated, but not between serum SC and IgA. Over the whole patient groups, serum SC is significantly related to serum IgM but not when patients with macroglobulinemia are excluded from the calculation. Serum SC is present as SC-IgM in macroglobulinemia and SC-IgM and SC-IgA in IgA myeloma.

Humans↗

Studies on circulating immune complexes of the liver diseases. 5. Anti-DNA antibodies and C1q binding activity.

Anti-dsDNA and anti-ssDNA antibodies, rheumatoid factors, HBsAg and C1q binding activity were determined in sera of patients with various liver diseases. Anti-dsDNA were only slightly increased in chronic aggressive hepatitis, activity severe and liver cirrhosis. A moderate elevation of anti-dsDNA was detected in possible lupoid hepatitis and it was highly increased in lupoid hepatitis as well as systemic lupus erythematosus. Non-specific elevation of anti-ssDNA titers were observed in all of the liver disease groups. In patients with increased anti-dsDNA titers, C1q binding activity and titers for rheumatoid factor and HBsAg tended to increase. According to reactivity of their sera to DNA, patients with liver disease could be divided in 4 groups: 1. high responders to dsDNA (lupoid hepatitis), 2. moderate responders to dsDNA (possible lupoid hepatitis or lupoid-like liver disease), 3. low responders (only positive for ssDNA), and 4. non-responders.

Antigen-Antibody Complex↗